Can you maybe just talk about how discussions with pharma customers have been trending so far this year, particularly as interest in AI appears to be evolving? And I am curious where de-identified ...

Management stated that these milestones further validate the potential benefits of nsPFA and increase awareness of the ...

Good morning, and welcome to Ocugen First Quarter 2026 Financial Results and Business Update. [Operator Instructions] I will now turn the call over to Tiffany Hamilton, Ocugen's Head of Corporate ...

Good morning, and thank you for joining us for the Neuronetics First Quarter 2026 Conference Call. Joining me on today's call is Neuronetics ...

Thank you, Trip. At Pulse Biosciences, we aren't just making a better medical device, we are creating a pulsed field ablation platform to completely shift how physicians treat disease.

Operator: Good day, and thank you for standing by. Welcome to Q1 2026 Grand Canyon Education, Inc. earnings conference call.

AI is transforming marriage counseling by making therapy more accessible, efficient, and personalized. From AI chatbots to ...

Operator: Thank you for standing by, and welcome to Corcept Therapeutics First Quarter 2026 Earnings Conference Call.

Commercial cell and gene therapy continues to represent a growing share of the revenue mix, and internal capability upgrades have positioned Cryoport for new sources of operational leverage in the ...

Total Revenue -- $247.6 million, an increase of 13% driven by a 4% rise in revenue days, a 2% increase in average guest spend ...

Your movements,” the neuroscientist and psychologist Lisa Feldman Barrett told me, “whether it’s on your face or in your body ...

KCCQ (Kansas City Cardiomyopathy Questionnaire): A standardized, patient-reported outcome tool that quantifies symptoms, functional status, and quality of life in heart failure patients.